AstraZeneca Cuts Sales Reps By Reducing PDI Contract; Will Others Follow?
AstraZeneca's decision to reduce the number of contract sales reps may be an early indicator of an industry trend in 2005
AstraZeneca's decision to reduce the number of contract sales reps may be an early indicator of an industry trend in 2005